12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Maestro Rechargeable regulatory update

EnteroMedics submitted a PMA to FDA for its Maestro Rechargeable (RC) System, which delivers VBLOC vagal blocking therapy to treat obesity. The...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >